All bills
S. 2398·119th Congress·Senate Bill

Kay Hagan Tick Reauthorization Act

Passed House & Senate (President next)Track

Latest action (15 Sep 2026): On motion to suspend the rules and pass the bill Agreed to by voice vote.

What this bill does

S. 2398, the Kay Hagan Tick Reauthorization Act, would extend federal funding authorization for two existing tick- and vector-borne disease programs under the Public Health Service Act. It reauthorizes the National Strategy and Regional Centers of Excellence in Vector-Borne Diseases program and the Enhanced Support to Assist Health Departments in Addressing Vector-Borne Diseases program, both previously authorized through 2025, extending them through 2026–2030. The bill also makes administrative changes to how the Centers of Excellence program is coordinated, removing a reference to the now-expired Tick-Borne Disease Working Group and adjusting the language describing coordination among federal agencies.

The bill primarily affects public health agencies, research centers, and state and local health departments that receive federal support for tracking and responding to tick-borne and other vector-borne illnesses, since it keeps their funding authorization active rather than letting it lapse.

Sponsored by Sen. Susan Collins (R-ME) and introduced July 23, 2025, the bill passed the Senate by voice vote on August 6, 2026, with an amendment. It next goes to the House of Representatives for consideration; it would need to pass the House and be signed by the President before becoming law.

Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.

Official summary

Kay Hagan Tick Reauthorization Act

This bill reauthorizes through FY2030 activities of the Centers for Disease Control and Prevention to address vector-borne diseases (e.g., diseases spread by bites from ticks or mosquitoes). These activities include (1) a national strategy, (2) grants for regional centers of excellence, and (3) cooperative agreements with state, local, and tribal health departments to increase capacity for preventing and responding to vector-borne diseases.

Timeline

  1. 15 Sep 2026

    On motion to suspend the rules and pass the bill Agreed to by voice vote.

  2. 6 Aug 2026

    Passed Senate with an amendment by Voice Vote.

  3. 30 Jul 2025

    Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.

Common questions

What does S. 2398 do?
S. 2398, the Kay Hagan Tick Reauthorization Act, would extend federal funding authorization for two existing tick- and vector-borne disease programs under the Public Health Service Act. It reauthorizes the National Strategy and Regional Centers of Excellence in Vector-Borne Diseases program and the Enhanced Support to Assist Health Departments in Addressing Vector-Borne Diseases program, both previously authorized through 2025, extending them through 2026–2030. The bill also makes administrative changes to how the Centers of Excellence program is coordinated, removing a reference to the now-expired Tick-Borne Disease Working Group and adjusting the language describing coordination among federal agencies. The bill primarily affects public health agencies, research centers, and state and local health departments that receive federal support for tracking and responding to tick-borne and other vector-borne illnesses, since it keeps their funding authorization active rather than letting it lapse. Sponsored by Sen. Susan Collins (R-ME) and introduced July 23, 2025, the bill passed the Senate by voice vote on August 6, 2026, with an amendment. It next goes to the House of Representatives for consideration; it would need to pass the House and be signed by the President before becoming law.
Has S. 2398 become law?
Not yet. As of 15 Sep 2026, S. 2398 is passed house & senate (president next).
Who sponsored S. 2398?
S. 2398 was sponsored by Sen. Susan Collins [R-ME] (Republican-ME), with 23 cosponsors.
What's the latest action on S. 2398?
On motion to suspend the rules and pass the bill Agreed to by voice vote. (15 Sep 2026).

Related bills in Health

Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.